A Regimen Combining the Wee1 Inhibitor AZD1775 With HDAC Inhibitors Targets Human Acute Myeloid Leukemia Cells Harboring Various Genetic Mutations

Leukemia - United Kingdom
doi 10.1038/leu.2014.296
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Acute Myeloid Leukemia With NPM1 Somatic Mutations

2020English

CDK9 Inhibitors in Acute Myeloid Leukemia

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2018English

Inhibitors of Histon Deacetylase (HDAC) and DNA Methyltransferase in Treatment Children With Acute Myeloid Leukemia, Effectiveness and Place

Russian Journal of Children Hematology and Oncology
2016English

A WEE1 Inhibitor Analog of AZD1775 Maintains Synergy With Cisplatin and Demonstrates Reduced Single-Agent Cytotoxicity in Medulloblastoma Cells

English

HAG Regimen Improves Survival in Adult Patients With Hypocellular Acute Myeloid Leukemia

Oncotarget
Oncology
2015English

Is There a Best Transplant Conditioning Regimen for Acute Myeloid Leukemia?

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2000English

Landscape of TET2 Mutations in Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

FLT3 Inhibitors in the Treatment of Acute Myeloid Leukemia

Cancer
Cancer ResearchOncology
2011English

Nucleophosmin Mutations in Acute Myeloid Leukemia in Children

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy